Article Information
History
- March 3, 2021.
Article Versions
- Version 1 (March 2, 2021 - 08:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Asaf Maoz*,1,
- Carter Merenstein*,1,
- Yusuke Koga2,
- Austin Potter1,
- Adam C. Gower1,
- Gang Liu1,
- Sherry Zhang1,
- Hanqiao Liu1,
- Christopher Stevenson3,
- Avrum Spira1,4,
- Mary E. Reid5,
- Joshua D. Campbell1,
- Sarah A. Mazzilli1,
- Marc E. Lenburg1 and
- Jennifer E. Beane+,1
- 1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
- 2Boston University, Bioinformatic Program, Boston, MA 02118, USA.
- 3Janssen Research and Development, High Wycombe HP12 4DP, UK.
- 4The Lung Cancer Initiative at Johnson and Johnson, Cambridge MA 02142, USA.
- 5Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
- ↵+Corresponding Author; email: jbeane{at}bu.edu
↵* These authors contributed equally to this work
Posted March 03, 2021.
Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions
